Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Gregor Tuschl
Observed names:
G Tuschl,
G. Tuschl,
Tuschl, Gregor
Institution:
Merck Healthcare KGaA, Darmstadt (Germany)
Observed institutions:
Merck KGaA, Darmstadt (Germany),
Johannes Gutenberg University Mainz,
Merck Healthcare KGaA, Darmstadt (Germany)
OpenAlex ID:
A5084023960
Primary Hepatocytes: Current Understanding of the Regulation of Metabolic Enzymes and Transporter Proteins, and Pharmaceutical Practice for the Use of Hepatocytes in Metabolism, Enzyme Induction, Transporter, Clearance, and Hepatotoxicity Studies
2007
·
Nicola J. Hewitt
, María José Gómez Lechón
, et al.
·
Drug Metabolism Reviews
·
834
Extracellular matrix modulates sensitivity of hepatocytes to fibroblastoid dedifferentiation and transforming growth factor β–induced apoptosis†
2009
·
Patricio Godoy
, Jan G. Hengstler
, et al.
·
Hepatology
·
264
Effects of cell culture conditions on primary rat hepatocytes—Cell morphology and differential gene expression
2005
·
Gregor Tuschl
, Stefan O. Mueller
·
Toxicology
·
119
Serum-free collagen sandwich cultures of adult rat hepatocytes maintain liver-like properties long term: A valuable model for in vitro toxicity and drug–drug interaction studies
2009
·
Gregor Tuschl
, Jens Hrach
, et al.
·
Chemico-Biological Interactions
·
103
Species-specific toxicity of diclofenac and troglitazone in primary human and rat hepatocytes
2008
·
Birthe Lauer
, Gregor Tuschl
, et al.
·
Chemico-Biological Interactions
·
87
Primary hepatocytes as a model to analyze species-specific toxicity and drug metabolism
2008
·
Gregor Tuschl
, Birthe Lauer
, et al.
·
Expert Opinion on Drug Metabolism & Toxicology
·
70
Use of mRNA expression to detect the induction of drug metabolising enzymes in rat and human hepatocytes
2008
·
L. Richert
, G. Tuschl
, et al.
·
Toxicology and Applied Pharmacology
·
61
Acceptable intakes (AIs) for 11 small molecule N-nitrosamines (NAs)
2023
·
Joel P. Bercu
, Melisa Masuda-Herrera
, et al.
·
Regulatory Toxicology and Pharmacology
·
37
Species Differences in the Response of Liver Drug-Metabolizing Enzymes to (S)-4-O-Tolylsulfanyl-2-(4-trifluormethyl-phenoxy)-butyric Acid (EMD 392949) in Vivo and in Vitro
2008
·
Lysiane Richert
, Gregor Tuschl
, et al.
·
Drug Metabolism and Disposition
·
26
Species-specific activation of nuclear receptors correlates with the response of liver drug metabolizing enzymes to EMD 392949 in vitro
2009
·
Stefan O. Mueller
, Yvonne Fery
, et al.
·
Toxicology Letters
·
12
Application of Short‐ and Long‐Term Hepatocyte Cultures to Predict Toxicities
2007
·
Gregor Tuschl
, Jens Hrach
, et al.
·
Wiley eBooks
·
10
What to consider for a good quality PDE document?
2019
·
Claudia Sehner
, Markus Schwind
, et al.
·
Pharmaceutical Development and Technology
·
9
Deriving harmonised permitted daily exposures (PDEs) for paracetamol (acetaminophen) CAS #: 103-90-2
2020
·
Kamila Gromek
, William Hawkins
, et al.
·
Regulatory Toxicology and Pharmacology
·
8
Comparison of permitted daily exposure (PDE) values for active pharmaceutical ingredients (APIs) - Evidence of a robust approach
2024
·
Claudia Sehner
, Tanja Bernier
, et al.
·
Regulatory Toxicology and Pharmacology
·
7
Alternatives in pharmaceutical toxicology: Global and focussed approaches - Two case studies
2007
·
Stefan O Mueller
, Gregor Tuschl
, et al.
·
ALTEX
·
7
Extracellular matrix modulates sensitivity of hepatocytes to fibroblastoid de-differentiation and TGF-β induced apoptosis
2009
·
P Godoy
, JG Hengstler
, et al.
·
Zeitschrift für Gastroenterologie
Long-term cell culture models for the analysis of hepatotoxicity in vitro
2007
·
Gregor Tuschl
, Jens Hrach
, et al.
·
Toxicology Letters
Show more works
View as search
Works count:
18
Citation count:
1,654
H-index:
10
I10-index:
11
Year
Topic
Type